2019 revenue up 10.5% for Theranostics and up 6% for IVD Excellent performance for Theranostics, particularly in France, with 19% growth11% overall growth in sales of LISA TRACKER® kits for routine useCash position at December…
Croissy-Beaubourg, January 29, 2020, 8:00am CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics of autoimmune diseases and theranostics, will publish its 2019 consolidated Full-year annual revenue and its cash…
Croissy-Beaubourg, January 8, 2020, 5.45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics of autoimmune diseases and theranostics, today announces its schedule for the publication of financial information for…